plerixafor has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Q; Feng, Y; Hou, FF; Liu, Y; Miao, J; Shen, W; Wu, Q; Zhou, L; Zhou, S | 1 |
| Advani, A; Advani, SL; Chen, LH; Connelly, KA; Gibson, IW; Gilbert, RE; Kabir, MG; Kelly, DJ; Marsden, PA; Sood, MM; Thai, K; Yuen, DA | 1 |
2 other study(ies) available for plerixafor and Chronic Kidney Diseases
| Article | Year |
|---|---|
C-X-C motif chemokine receptor 4 aggravates renal fibrosis through activating JAK/STAT/GSK3β/β-catenin pathway.
Topics: Amino Acid Motifs; Animals; Benzylamines; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Chemokine CXCL12; Cyclams; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Gene Knockdown Techniques; Glycogen Synthase Kinase 3 beta; Humans; Janus Kinase 2; Kidney; Matrix Metalloproteinase 7; Mice; Pyrimidinones; Receptors, CXCR4; Renal Insufficiency, Chronic; STAT3 Transcription Factor; STAT6 Transcription Factor | 2020 |
SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzylamines; Biopsy; Capillaries; Cell Line; Chemokine CXCL12; Cyclams; Fibrosis; Glomerulosclerosis, Focal Segmental; Heterocyclic Compounds; Humans; Immunohistochemistry; Kidney; Kidney Function Tests; Nephrectomy; Nitric Oxide Synthase Type III; Perindopril; Phosphorylation; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; Renal Insufficiency, Chronic; RNA, Messenger; Serine; Signal Transduction | 2014 |